Short-term gov­ern­ment spend­ing bill in­cludes reau­tho­riza­tions of or­phan drug cred­its and oth­er phar­ma perks

As bi­par­ti­san talks for a longer-term gov­ern­ment spend­ing bill con­tin­ue, House Ap­pro­pri­a­tions Chair Rosa De­Lau­ro (D-CT) to­day filed a one-week con­tin­u­ing res­o­lu­tion to keep the gov­ern­ment fund­ed and avert a shut­down on Fri­day at mid­night.

The short-term Band-Aid al­so in­cludes sev­er­al reau­tho­riza­tions that are of in­ter­est to the phar­ma in­dus­try as they had been cut out of a re­cent­ly passed FDA-in­dus­try user fee deal, which was tagged on­to the last short-term fund­ing ex­ten­sion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.